A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies
A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies is a paper indexed in PICO Portal from OpenAlex.
How many citations does A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies have?
A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies has 257 citations in the OpenAlex counts PICO Portal stores.
When was A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies published?
A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies has 2015 year in the PICO Portal index.
What is the open-access status of A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies?
A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies has closed oa status in the PICO Portal index.
What is the DOI of A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies?
The DOI for A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies is on the source record.
What is the PMID of A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies?
The PMID for A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies is on the source record.
What is the OpenAlex record for A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies?
The OpenAlex for A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies is on the source record.